The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes.

Diabetes Care
Maria Giovanna ScaraleClaudia Menzaghi

Abstract

Type 2 diabetes is characterized by increased death rate. In order to tackle this dramatic event, it becomes essential to discover novel biomarkers capable of identifying high-risk patients to be exposed to more aggressive preventive and treatment strategies. hs-CRP and serum amyloid P component (SAP) are two acute-phase inflammation proteins, which interact physically and share structural and functional features. We investigated their combined role in associating with and improving prediction of mortality in type 2 diabetes. Four cohorts comprising 2,499 patients with diabetes (643 all-cause deaths) were analyzed. The improvement of mortality prediction was addressed using two well-established prediction models, namely, EstimatioN oF mORtality risk in type 2 diabetiC patiEnts (ENFORCE) and Risk Equations for Complications of Type 2 Diabetes (RECODe). Both hs-CRP and SAP were independently associated with all-cause mortality (hazard ratios [HRs] [95% CIs]: 1.46 [1.34-1.58] [P < 0.001] and 0.82 [0.76-0.89] [P < 0.001], respectively). Patients with SAP ≤33 mg/L were at increased risk of death versus those with SAP >33 mg/L only if hs-CRP was relatively high (>2 mg/L) (HR 1.96 [95% CI 1.52-2.54] [P < 0.001] and 1.20 [0.91-1.57] [P...Continue Reading

References

Feb 11, 1999·The New England Journal of Medicine·C Gabay, I Kushner
Jun 17, 2006·Nature Reviews. Immunology·Göran K Hansson, Peter Libby
Dec 2, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Nancy Swords JennyBruce M Psaty
Mar 19, 2008·Current Medical Research and Opinion·Harold E BaysUNKNOWN SHIELD Study Group
Oct 1, 2008·Journal of Internal Medicine·J P CasasM B Pepys
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
Jul 2, 2009·JAMA : the Journal of the American Medical Association·Paul ElliottJaspal S Kooner
Dec 9, 2009·Annual Review of Immunology·Barbara BottazziAlberto Mantovani
Jan 5, 2011·Statistics in Medicine·Michael J PencinaEwout W Steyerberg
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
Jul 16, 2015·The New England Journal of Medicine·Duncan B RichardsMark B Pepys
Oct 29, 2015·The New England Journal of Medicine·Mauro TancrediMarcus Lind
Jul 21, 2017·The New England Journal of Medicine·Aidin RawshaniSoffia Gudbjörnsdottir
Jul 21, 2017·The New England Journal of Medicine·Elisabet Martínez-Cerón, Francisco García-Río
Jun 19, 2018·Critical Care Medicine·Brendan J KellyUNKNOWN Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program
Nov 22, 2018·Frontiers in Immunology·Darrell Pilling, Richard H Gomer
May 16, 2019·The Journal of Clinical Endocrinology and Metabolism·Massimiliano CopettiVincenzo Trischitta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.